Theoretically, a stable complex such as AHK-Cu could help or restore copper balance in neurological conditions, but this is still a theoretical concept that needs much more research before using in clinical settings
Some of the AHK-Cu skin serums we evaluated use 0.3-1% AHK-Cu
This approach is especially meaningful for those managing chronic conditions, caregiving duties, or other circumstances that make regular travel to clinical sites impractical
declares having received consulting honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk and Bayer, and research grants from British Heart Foundation, MRC (UK), NIHR, PHE, MSD, Pfizer, Aegerion, Colgate and Roche